3 Big Deals (Podcast)

| About: Starz (STRZA)
This article is now exclusive for PRO subscribers.

Summary

One done deal (Endurance-Constant Contact).

One signed deal (ChemChina-Syngenta).

One future deal (Starz).

Starz's Outlander

Rangeley Capital's portfolio managers Andrew Walker and Chris DeMuth Jr host a fifteen-minute podcast, which you can subscribe to on Apple's iTunes, Stitcher, or SoundCloud. If you missed the previous podcast episode, then please check out "Buying At Wal-Mart, Selling On Amazon".

In the current episode, we talk about the Endurance (NASDAQ:EIGI) acquisition of Constant Contact (NASDAQ:CTCT). For background reading, please check out "Investing With An Edge: Constant Contact". We also talk about the acquisition of Syngenta (NYSE:SYT) and potential acquisition of Starz (NASDAQ:STRZA).

Disclosure: I am/we are long EMC, CTCT, STRZA, SYT.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Chris DeMuth Jr and Andrew Walker are portfolio managers at Rangeley Capital. Rangeley invests with a margin of safety by buying securities at deep discounts to their intrinsic value and unlocking that value through corporate events. In order to maximize total returns for our investors, we reserve the right to make investment decisions regarding any security without further notification except where such notification is required by law.